Three more biotechs hit Nas­daq as the sec­tor, now with more than $13B raised, con­tin­ues bar­rel­ing to­ward record

Ed­i­tor’s note: In­ter­est­ed in fol­low­ing bio­phar­ma’s fast-paced IPO mar­ket? You can book­mark our IPO Track­er here.

Af­ter a sum­mer slum­ber, the biotech IPO mar­ket is back in full swing with three new pric­ings drop­ping Wednes­day and two SPACs en­ter­ing the ring.

DiCE Ther­a­peu­tics and Tyra Bio­sciences each hit Nas­daq on Wednes­day with nine-fig­ure rais­es, while small-cap Pa­sithea Ther­a­peu­tics al­so de­buted with a $24 mil­lion raise. The pric­ings have pushed the com­bined in­dus­try raise north of $13 bil­lion so far in 2021, per the End­points News track­er, a fig­ure like­ly to eclipse last year’s record to­tal of $16.5 bil­lion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER